To advance the strategy of coadministration of peripheral GABA intake and GABA-T inhibitory drugs as a novel and effective anti-obesity intervention, further studies are essential to elucidate its peripheral and central mechanisms of action. The gene discussed is ABAT; the disease is Obesity.